MAZE - Maze Therapeutics, Inc. Common Stock -  [ ]

Seasonality of Returns By Period

Average daily return by calendar bucket (ClosePriceSA).

Day of Week

Week of Month

Month of Year

Seasonal Path

YTD vs Last Year vs Lookback Avg · closes rebased to 100 at each year's first session
Ticker Details
Maze Therapeutics, Inc. Common Stock
IPO Date: January 31, 2025
Sector: Healthcare
Industry: Biotechnology
Market Cap: $1.25B
Activated in VL: True
Average Daily Range
Avg Daily Range: $0.84 | 3.93%
Avg Daily Range (30 D): $0.76 | 2.82%
Avg Daily Range (90 D): $0.68 | 2.48%
Institutional Daily Volume
Avg Daily Volume: .39M
Avg Daily Volume (30 D): .36M
Avg Daily Volume (90 D): .41M
Trade Size
Avg Trade Size (Sh.): 63
Avg Trade Size (Sh.) (30 D): 50
Avg Trade Size (Sh.) (90 D): 52
Institutional Trades
Total Institutional Trades: 534
Avg Institutional Trade: $2M
Avg Institutional Trade (30 D): $2.07M
Avg Institutional Trade (90 D): $2.23M
Avg Institutional Trade Volume: .07M
Avg Institutional Trades (Per Day): 1
Market Closing Trades
Avg Closing Trade: $2.32M
Avg Closing Trade (30 D): $1.9M
Avg Closing Trade (90 D): $2.5M
Avg Closing Volume: 79.82K
 
News
May 7, 2026 @ 12:12 PM
Maze Therapeutics CSBO Sells 7,500 Shares for $190...
Source: Sarah Sidlow
Apr 22, 2026 @ 4:09 AM
Maze Therapeutics Announces $150 Million Registere...
Source: Not Specified
Apr 4, 2026 @ 11:36 PM
Maze Therapeutics' Chief Medical Officer Sold 100%...
Source: Robert Izquierdo
Mar 22, 2026 @ 2:17 AM
Maze Therapeutics President Sells All Insider Shar...
Source: Adé Hennis
Feb 16, 2026 @ 6:35 AM
Maze Therapeutics Chief Medical Officer Sells 15K ...
Source: Adé Hennis
Financials
  TTM Q2 2026 Q1 2026
Basic EPS $-2.47 $-.76 $-.45
Diluted EPS $-2.47 $-.76 $-.45
Revenue $20M $M $20M
Gross Profit
Net Income / Loss $-133.59M $-44.73M $-24.21M
Operating Income / Loss $-145.61M $-48.04M $-26.55M
Cost of Revenue
Net Cash Flow $-61.9M $3.88M $9.52M
PE Ratio